Rosie Lawrence

Background

Rosie joined the Dehns Brighton office in October 2020 after completing a Master’s degree (Distinction) at the University of Southampton. Her dissertation classified variants in congenital heart disease patients to investigate the presence of undiagnosed primary ciliopathies.

Rosie’s undergraduate degree, at the University of Cambridge, focused on Genetics in the final year, with a project involving CRISPR/Cas9 mutagenesis of Drosophila melanogaster lines. The project aimed to determine the effect of Plp mutagenesis on female fertility and egg chamber morphology.

She is a Trainee Patent Attorney in the Dehns Biotechnology Group.

Types of client and client work

Rosie has experience with a broad range of clients including Universities (and their associated spin out companies) and small- to medium-sized companies, and a few multinational corporations.
The majority of her work relates to the filing and prosecuting of patent applications in Europe and other jurisdictions worldwide.

Expertise

Rosie is involved in patent work in many areas of biotechnology and biochemistry, including genomics, recombinant nucleic acid and protein products, screening methods, transgenic plants, diagnostic assays, microbiology and probiotics, virology and vaccines.

Qualifications and Memberships

• Postgraduate Certificate in Intellectual Property Law, Bournemouth University, 2022
• Pre-European Qualification Exam, 2023

Higher Education

• BA (Hons) Natural Sciences (Biological Sciences), University of Cambridge, 2019
• MSc (Distinction), Genomic Medicine, University of Southampton, 2020

Other

Rosie featured in an episode of Dehns’ “The IP Podcast” where she discussed her experiences of studying STEM subjects at school and then entering a STEM profession as a woman – this podcast was part of Dehns’ contribution to “International Day of Women and Girls in STEM” in February 2023.